Equity markets end lower, though commodity prices staged a huge squeeze higher...
Vertex Pharmaceuticals' 52-Week High Driven by Kalydeco
Celgene, BioMarin and Vertex are RBC's Top Biotech Buys
Biotech Stock Roundup: BioMarin to Acquire Prosensa, AbbVie HCV Therapy Closer to EU Approval
Today's Stocks Driving Success For The Drugs Industry
It was another slow, low volume, lackluster trading session
Vertex to Present at Deutsche Bank BioFEST on December 2
Vertex to Present at Deutsche Bank BioFEST on December 2
Insider Trading Alert - LNKD, VRTX And RLGY Traded By Insiders
The S&P failed to extend its 4-day winning streak following headlines out of the Fed
Foundation sells $3.3B in Vertex drug royalties
Foundation sells $3.3B in Vertex drug royalties
Royalty Pharma's $3.3 Billion Transaction is Bullish for Vertex Pharma
Midday movers: Target, JetBlue, Qualcomm & more
Barbarian At The Gate: Vertex Pharmaceuticals (VRTX)
3 Drugs Stocks Driving The Industry Higher
Royalty Pharma buys royalties on Vertex Pharma drugs for $3.3 bln
Royalty Pharma Pays $3.3 Billion for Cystic Fibrosis Royalties
VERTEX PHARMACEUTICALS INC / MA Financials
Biotech Stock Roundup: Gilead, AbbVie Score at Liver Meeting, Dendreon Files for Bankruptcy
Vertex Pharmaceuticals Seeks Approval for CF Combination
VERTEX PHARMACEUTICALS INC / MA Files SEC form 10-Q, Quarterly Report
3 Stocks Moving The Drugs Industry Upward
Coverage initiated on Vertex Pharm by CRT Capital
Vertex to Present at the Credit Suisse Healthcare Conference on November 11
Vertex tops Street 3Q forecasts
Vertex Reports Third Quarter 2014 Financial Results
US STOCKS-Wall St rallies, S&P back above 14-day moving average
US STOCKS-Biotech shares drop, Amarin plunges 20 pct
US STOCKS-S&P 500 rebounds with energy shares; Dow dips
US STOCKS-Wall St down slightly, financials help limit losses
Vertex Pharma posts bigger 2Q loss
Vertex Receives European CHMP Positive Opinion for KALYDECOTM (ivacaftor) in Eight Non-G551D Gating Mutations
Ahead of the Bell: Vertex soars on study
Vertex ends hepatitis C investment as sales fall
Gilead profit triples, hepatitis C drug sales beat by $1 billion
Vertex to Present at the Barclays Global Healthcare Conference on March 11
Vertex to Present at the RBC Global Healthcare Conference on February 25
Vertex Pharma rises despite lower Incivek sales
Vertex posts profit on royalty deal for hep C drug
Vertex Reviews Corporate Strategy and Outlines Key 2014 Business Priorities at the 32nd Annual J.P. Morgan Healthcare Conference
Vertex Announces Appointment of Jeffrey A. Chodakewitz, M.D., as Chief Medical Officer and Senior Vice President of Global Medicines Development
Vertex Announces Upcoming Presentation at J.P. Morgan Healthcare Conference and Date of Fourth Quarter and Full Year 2013 Financial Results
Vertex Announces Results of Phase 3 Study of Ivacaftor in People with CF who have the R117H Mutation
Vertex Pharmaceuticals Incorporated Plays the Earnings Waiting Game
The Spark of Innovation at Vertex Pharmaceuticals Incorporated
Why Boston Scientific Corporation, Regeneron Pharmaceuticals, Inc., and Vertex ...
Why Vertex Pharmaceuticals Incorporated, Alexion Pharmaceuticals, Inc., and ...
Stock Update: Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Stock Insights On Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Why Valero Energy Corporation, Phillips 66, and Vertex Pharmaceuticals ...
Vertex Pharmaceuticals Incorporated's (VRTX) CEO Jeffrey Leiden on Q2 2014 ...
Better Biotech Buy: Vertex Pharmaceuticals Incorporated vs. BioMarin ...
Vertex Pharmaceuticals Inc. (VRTX): New Analyst Report from Zacks Equity ...
